Wikimd logo

W8MD Diet | COVID-19 portal | Vitamin D | Vaccine | Keto

WikiMD is the world's largest medical encyclopedia with
13,951 pages, 4,144,379 edits & 41,614,182 views.

Free unbiased diet, health and wellness info!


From WikiMD's free health, diet & wellness encyclopedia
Jump to navigation Jump to search

Abgn-168h - a humanized, agonistic monoclonal antibody against p selectin glycoprotein ligand-1 (psgl-1; selplg; cd162), with potential immunosuppressive activity. Upon administration, neihulizumab specifically targets and binds to cd162 expressed on activated t-lymphocytes. This induces apoptosis of activated t-cells and reduces t-cell-mediated immune responses. This may halt disease progression of t-cell-mediated autoimmune diseases and acute graft-versus-host disease (gvhd). Also see neihulizumab

Up to date info


Latest research - Abgn-168h

Clinical trials

Source: Data courtesy of the U.S. National Library of Medicine. Since the data might have changed, please query MeSH on Abgn-168h for any updates.


Abgn-168h is part of WikiMD's free ^articles!

^Abgn-168h (article) is provided for informational purposes only. No expressed or implied warranties as to the validity of content.
WikiMD is not a substitute for professional advice. By accessing and using WikiMD you agree to the terms of use.
Templates etc. when imported from Wikipedia, are licensed under CC BY-SA 3.0. See full disclaimers.
W8MD weight loss logo

Ad. Tired of being overweight?. W8MD's physician weight loss program can HELP. Tele medicine available